Semaglutide Weight Loss in Suwanee, GA: GLP-1 Injections With Medical Supervision
Physician-supervised, once-weekly GLP-1 injections that curb appetite and support steady, lasting weight loss.
- Dosing
- Weekly injection
- Downtime
- None
- First Results
- 4 to 8 weeks
- Supervision
- Physician-led
Personalized Semaglutide Weight Loss Care
Semaglutide is a once-weekly GLP-1 injection for medical weight loss in Suwanee, GA, proudly serving patients from Johns Creek, Alpharetta, Duluth, Cumming and across Metro Atlanta. It works with your biology to reduce hunger and food noise, helping you lose weight steadily when diet and willpower alone have stopped working.
At Bodiatrics, every semaglutide program is directed by Dr. Will Johnson, MD, FACS, a Duke-trained, board-certified bariatric surgeon with more than 20 years of experience in weight management. He pairs GLP-1 therapy with baseline testing and ongoing monitoring so your dose, nutrition, and progress are guided by data, not guesswork. Learn more about Dr. Will Johnson and his whole-person approach.
When Diets Stop Working: How Semaglutide Changes the Equation
Many patients arrive at Bodiatrics after years of effort. You have followed structured diets, tracked calories, joined gyms, and worked with coaches, sometimes with short-term success followed by regain. Constant hunger, fatigue, and a scale that barely moves are common, and it is easy to blame yourself. In reality, obesity changes the hormones that control appetite, fullness, and blood sugar, so the same non-surgical approach wears you down while the weight creeps back. That pattern is biology, not a lack of willpower.
Understanding Appetite Biology
Semaglutide interrupts that cycle. It mimics GLP-1, a natural gut hormone released after eating, which signals fullness to the brain, slows how quickly the stomach empties, and steadies blood sugar. The result is earlier satiety, quieter hunger, and less of the food noise that drives overeating. Combined with baseline testing, nutrition guidance, and physician monitoring at Bodiatrics, most patients lose weight steadily over several months while protecting muscle and building habits that make results easier to keep.
What Is Semaglutide and How Do GLP-1 Injections Work?
Semaglutide is a once-weekly GLP-1 receptor agonist that mimics a gut hormone released after meals, reducing appetite, slowing stomach emptying and improving blood sugar control. It is one physician-supervised option within medical weight loss in Suwanee, GA, always guided by baseline testing.
Wegovy is the brand approved for chronic weight management; in the STEP 1 trial 2.4 mg cut body weight about 15 percent. Ozempic is the same molecule approved for diabetes and prescribed off-label. The NIDDK ranks GLP-1s among the most effective non-surgical tools for obesity.
- Dosing
- Once weekly (a small self-injection)
- First Signs
- 4 to 8 weeks (appetite and portions shift)
- Full Effect
- Over several months (steady, sustained loss)
- Downtime
- None (no procedure involved)
Where Semaglutide Weight Loss Helps
Semaglutide does more than curb appetite - it changes the hormonal signals that make weight loss hard to sustain. Dr. Will Johnson at Bodiatrics uses it to address:
-
Obesity
Reduces appetite and food noise to drive steady, meaningful weight loss
-
Difficulty Losing Weight
Helps break plateaus when diet and exercise alone have stalled
-
Type 2 Diabetes
Improves blood sugar control alongside weight reduction
-
Weight Regain
Supports appetite regulation to reduce the cycle of rebound weight
-
Prediabetes and Insulin Resistance
Steadies blood sugar and supports metabolic health
-
High Blood Pressure
Weight reduction often eases blood pressure and heart strain
Benefits of Semaglutide GLP-1 Weight Loss
Steady, Supervised Results
2000+ Satisfied patients
- 01
Significant Weight Loss
STEP 1 trial showed about 15 percent average body-weight reduction
- 02
Reduced Hunger
Quiets appetite and food noise so healthier eating feels sustainable
- 03
Once-Weekly Dosing
A single weekly injection fits easily into a busy schedule
- 04
No Downtime
A non-surgical option with no recovery period required
- 05
Better Blood Sugar
Improves glucose control, a benefit for type 2 diabetes and prediabetes
- 06
Baseline Testing Included
Every program includes lab and metabolic testing to guide your plan
- 07
Physician Supervision
Dr. Johnson monitors dosing, safety, and progress throughout
Semaglutide vs. Other Weight Loss Options
Semaglutide offers strong, non-surgical weight loss with once-weekly dosing, positioned between lifestyle programs and bariatric surgery.
| Treatment | Mechanism | Time | Results | Duration | Downtime | Best For |
|---|---|---|---|---|---|---|
| Semaglutide (GLP-1) | Single GLP-1 receptor agonist | Weekly injection | About 15% average loss | While on medication | None | Non-surgical candidates |
| Tirzepatide | Dual GLP-1 and GIP agonist | Weekly injection | Up to about 21% loss | While on medication | None | Those wanting maximum drug loss |
| Gastric Sleeve Surgery | Removes 75-80% of stomach | 1 to 2 hours | Significant lasting loss | Permanent anatomy change | 1 to 2 weeks | BMI 35-plus with conditions |
| Weight Loss Packages | Bundled testing plus program | Ongoing program | Personalized results | Program length | None | Comprehensive, guided care |
Who Is a Good Candidate for Semaglutide?
Semaglutide helps most when biology, not effort, is driving the problem: when diet, exercise, and lifestyle changes have repeatedly stalled or weight keeps returning. Candidacy at Bodiatrics is determined by data, health history, and physiology, and every program begins with baseline lab and metabolic testing rather than assumptions. Some patients do well on GLP-1 therapy long term, while others use it as a step before or after other options.
Ideal Candidates for Semaglutide
- Adults with obesity, or overweight with a related condition such as type 2 diabetes or high blood pressure
- Patients whose diet and exercise efforts have repeatedly stalled or led to regain
- Those seeking a non-surgical, physician-supervised weight loss option
- Patients willing to follow nutrition guidance and attend monitoring visits
- Those with realistic expectations about gradual, steady results
Who Should Wait or Avoid Semaglutide
- Anyone who is pregnant, breastfeeding, or planning pregnancy
- Patients with a personal or family history of medullary thyroid carcinoma or MEN 2
- Those with a history of pancreatitis or certain gastrointestinal conditions
- Anyone with a known hypersensitivity to semaglutide
During your consultation, Dr. Johnson reviews your history, medications, and goals, then recommends semaglutide, tirzepatide, a program, or surgery based on what fits your physiology.
What Happens During Your Semaglutide Program
Baseline Testing
Plan and Prescription
Weekly Injection
Titration
Monitoring
Risks and Side Effects
What to Know
-
Common Side Effects
The most common side effects are gastrointestinal: nausea, mild vomiting, diarrhea, constipation, and reduced appetite, especially when the dose is first increased. These are usually mild to moderate and improve as your body adjusts. Slow dose titration, smaller meals, and staying hydrated help most patients manage them comfortably.
-
Uncommon Serious Risks
Rare but more serious risks include pancreatitis, gallbladder problems, and low blood sugar when semaglutide is combined with certain diabetes medications. It carries a boxed warning regarding thyroid C-cell tumors seen in rodents, so it is avoided in patients with a personal or family history of medullary thyroid carcinoma or MEN 2.
-
Safety and Supervision
Physician oversight matters a great deal here. According to the U.S. Food and Drug Administration, semaglutide should be used under medical supervision with FDA-approved products rather than compounded alternatives. Dr. Johnson screens each patient, monitors dosing at every visit, and adjusts the plan to keep therapy both safe and effective.
Semaglutide Cost in Suwanee
Pricing and Payment Options
How Much Does Semaglutide Weight Loss Cost in Suwanee?
The cost of a semaglutide program depends on several factors, including the formulation and dose, the baseline testing included in every program, and the level of monitoring and support you receive. Because each patient's physiology and goals differ, Bodiatrics discusses exact pricing during your personalized consultation. Our physician-supervised programs bundle testing and follow-up so you understand the full value, and our team helps verify insurance coverage where it applies to GLP-1 therapy.
Flexible Payment Options
To make treatment accessible, Bodiatrics accepts financing so you can spread the cost over time. Learn more on our weight loss financing options page.
- Cherry - Fast approval with flexible monthly payment plans and no hard credit impact to check your rate.
- CareCredit - A dedicated health and wellness credit line with promotional financing options.
Why Choose Bodiatrics for Semaglutide in Suwanee, GA
Physician-Led, Data-Driven
-
Physician Oversight
A board-certified surgeon directs your GLP-1 therapy, not a mill
-
Baseline Testing Included
Metabolic and lab testing guide dosing from day one
-
Whole-Person Approach
Nutrition, coaching, and monitoring support each program
-
Full Continuum of Care
Medical and surgical options under one roof as needs change
Related Treatments
Complementary treatments to support your goals.
Featured treatment Tirzepatide Weight Loss A dual-action weekly injection that quiets appetite and improves how your body uses energy, guided by a physician. 
Featured treatment Dietitian and Nutritionist Services Personalized nutrition counseling with a registered dietitian, built around your body, your goals, and your real daily routine. Frequently Asked Questions About Semaglutide
Your Questions Answered
How much does semaglutide weight loss cost in Suwanee?
Semaglutide cost is discussed during your consultation because it depends on the formulation, dose, and the baseline testing and monitoring included in your program. Bodiatrics offers physician-supervised programs that bundle testing and follow-up into clear value. Financing through Cherry and CareCredit is available, and our team helps verify insurance when GLP-1 coverage applies.
How long do I need to stay on semaglutide?
Semaglutide works while you take it, so many patients continue for the long term to maintain results, much like other chronic-condition medications. Some transition off gradually with a strong nutrition and lifestyle foundation. Dr. Johnson reviews your progress at each visit and adjusts your plan, including duration, based on your response and goals.
Does the semaglutide injection hurt?
The semaglutide injection uses a very fine needle and is given just under the skin, so most patients feel only a brief pinch or nothing at all. You self-administer it once weekly at home after simple training at your visit. Any soreness at the injection site is usually mild and passes quickly.
When will I see results from semaglutide?
Most patients notice reduced appetite within the first few weeks as the dose is gradually increased. Visible weight loss typically develops over the first 3 to 6 months and continues with ongoing therapy. Your pace depends on your starting point, dose, overall health, and how closely you follow nutrition guidance and monitoring visits.
What is the difference between Ozempic and Wegovy?
Ozempic and Wegovy contain the same active ingredient, semaglutide, but different FDA approvals. Wegovy is FDA-approved for chronic weight management, while Ozempic is approved for type 2 diabetes and may be prescribed off-label for weight loss. Dr. Johnson determines the right product and dose for your goals and health history.
How does semaglutide compare to tirzepatide?
Semaglutide activates one hormone pathway (GLP-1), while tirzepatide is a dual agonist that activates both GLP-1 and GIP, which produced up to about 21 percent weight loss in trials versus about 15 percent for semaglutide. Both are once-weekly injections. Learn more about /medical-weight-loss/tirzepatide-weight-loss/ to compare options with Dr. Johnson.
Is baseline testing really included?
Yes. Every semaglutide program at Bodiatrics includes baseline lab and metabolic testing, which is a core part of our physician-supervised approach. This testing helps Dr. Johnson dose safely, monitor your health, and protect muscle as you lose weight. You can learn more about our /baseline-testing/ before starting therapy.
Can men take semaglutide for weight loss?
Yes, semaglutide benefits both men and women. Men often wait longer to seek care, sometimes until related conditions like high blood pressure or type 2 diabetes appear, so earlier evaluation is valuable. Candidacy is based on health history, BMI, and related conditions rather than gender, and each plan is tailored to the individual.
Is semaglutide safe?
Semaglutide has a strong safety profile when used under medical supervision with FDA-approved products. Side effects are usually mild and gastrointestinal, especially early on. Serious risks are uncommon and screened for during your evaluation. Dr. Johnson reviews your history, monitors dosing, and adjusts your plan to keep therapy safe and effective.
Will I regain weight if I stop semaglutide?
Some weight regain is possible after stopping semaglutide because appetite signals return, which is why Bodiatrics pairs medication with nutrition, coaching, and monitoring. Building sustainable habits during treatment helps protect results. Dr. Johnson works with you on a long-term strategy, whether that means continuing therapy or transitioning off gradually with support.
Schedule Your Semaglutide (GLP-1) Weight Loss Consultation
References
- Wilding et al., New England Journal of Medicine. (2021). In the STEP 1 trial, once-weekly semaglutide 2.4 mg produced about a 15 percent mean reduction in body weight. PMID: 33567185.
- Kushner et al., Obesity. (2020). Overview of the STEP 1 to 5 clinical trial program evaluating semaglutide for chronic weight management. PMID: 32441473.
- Lincoff et al., New England Journal of Medicine. (2023). In the SELECT trial, semaglutide reduced major cardiovascular events in adults with obesity and cardiovascular disease without diabetes. PMID: 37952131.
- Pi-Sunyer et al., New England Journal of Medicine. (2015). Liraglutide 3.0 mg, an earlier GLP-1 medication, produced clinically meaningful weight loss in adults with overweight or obesity. PMID: 26132939.
- National Institute of Diabetes and Digestive and Kidney Diseases. (2024). Overview of prescription medications, including GLP-1 agonists, for overweight and obesity.